Benzinga's Top Upgrades, Downgrades For December 23, 2020
Downgrades Roth Capital downgraded the previous rating for Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) from Buy to Sell. Arcturus Therapeutics earned $0.92 in the third quarter, compared to $0.5...